InvestorsHub Logo
Followers 49
Posts 11381
Boards Moderated 0
Alias Born 06/15/2014

Re: Triple88 post# 424095

Thursday, 05/09/2024 10:44:39 AM

Thursday, May 09, 2024 10:44:39 AM

Post# of 426436
Not necessarily. What this highlights is the poor return of partnerships. I believe JT mentioned this dynamic when considering partnerships in the EU. V just becomes one out of a hundred other drugs in the salesperson’s bag. Plus they will usually focus their efforts on pushing the drugs that are most profitable to their company. Only way BP really pushes V is if they own it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News